3 Life Science Cos. Bolster IPO Pipeline With $101M In Deals
Three life science companies have filed initial public offerings this week estimated to raise a combined $101.5 million, led by a $60 million deal proposed by Gemphire Therapeutics Inc., bolstering an...To view the full article, register now.
Already a subscriber? Click here to view full article